Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients

INTRODUCTION: The main treatment regimen for small cell lung cancer (SCLC) involves platinum-based chemotherapy (cisplatin or carboplatin) and etoposide. Single nucleotide polymorphisms (SNPs) in TOP2A and ERCC1 genes were tested as prognostic and predictive factors in non-small cell lung cancer (NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicoś, Marcin, Rolska-Kopińska, Anna, Krawczyk, Paweł, Grenda, Anna, Bożyk, Aleksandra, Szczyrek, Michał, Milanowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959040/
https://www.ncbi.nlm.nih.gov/pubmed/33747282
http://dx.doi.org/10.5114/aoms.2020.92572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959040/
https://www.ncbi.nlm.nih.gov/pubmed/33747282
http://dx.doi.org/10.5114/aoms.2020.92572

Ejemplares similares